Overview of Ivermectin
Ivermectin, with the NDC code 42799-806, is a semisynthetic, anthelmintic agent used for oral administration. It is derived from the avermectins and is labeled and distributed by Edenbridge Pharmaceuticals LLC[1][4].
Market Context
The US pharmaceutical market, within which ivermectin operates, is projected to grow significantly. From $846.72 billion in 2022, the market is expected to reach $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[3].
Current Market Position
Ivermectin falls under the category of small molecules, which held the largest market share in 2022. The small molecules segment, including both generic and branded drugs, is a dominant force in the US pharmaceutical market[3].
Pricing Trends
General Pricing Trends in the Pharmaceutical Market
Price increases for prescription drugs are a common phenomenon, particularly in January and July of each year. In 2022, over 3,000 drugs experienced price increases in January, with an average increase of nearly $150 per drug (10% increase). July saw fewer but more significant increases, often affecting higher-priced drugs[2].
Specific Pricing for Ivermectin
As of the latest available data, ivermectin tablets with the NDC code 42799-806 have an active ingredient strength of 3 mg per tablet. However, specific price changes for this particular NDC code are not detailed in the general reports on pharmaceutical price trends.
Factors Influencing Price
Regulatory Environment
The pricing of ivermectin, like other generic drugs, is influenced by regulatory approvals and market competition. The Abbreviated New Drug Application (ANDA) status of ivermectin allows for multiple manufacturers to produce the drug, which can lead to competitive pricing[1][4].
Market Demand and Supply
The demand for ivermectin can fluctuate based on the prevalence of the conditions it treats, such as parasitic infections. Increased demand, especially during public health crises, can lead to price adjustments.
Production Costs and R&D Investments
While ivermectin is a generic drug and thus less affected by the high costs of research and development (R&D) compared to new biologics or small molecules, any changes in production costs or raw material prices can influence its market price.
Price Projections
Given the general trends in the pharmaceutical market:
Short-Term Projections
- January and July Price Increases: Ivermectin prices may follow the general trend of seeing price increases in January and July, although the magnitude of these increases is likely to be moderate compared to higher-priced drugs[2].
Long-Term Projections
- Market Growth: As the US pharmaceutical market grows, the demand for generic drugs like ivermectin is expected to remain stable or increase, potentially leading to slight price adjustments to reflect market dynamics.
- Competition: The presence of multiple generic manufacturers can keep prices competitive, but significant price increases are less likely for well-established generic drugs like ivermectin.
Key Takeaways
- Market Growth: The US pharmaceutical market is expected to grow significantly, but this growth may not directly translate to substantial price increases for generic drugs like ivermectin.
- Pricing Trends: Price increases for ivermectin are likely to be moderate and aligned with general trends in the pharmaceutical market.
- Regulatory and Competitive Factors: The ANDA status and competitive market for ivermectin will continue to influence its pricing.
FAQs
Q: What is the current dosage and strength of ivermectin tablets with NDC code 42799-806?
A: The current dosage and strength of ivermectin tablets with NDC code 42799-806 is 3 mg per tablet[1].
Q: How does the US pharmaceutical market growth impact generic drugs like ivermectin?
A: The growth of the US pharmaceutical market can lead to increased demand for generic drugs, but this does not necessarily result in significant price increases due to competitive market dynamics[3].
Q: What are the typical times of the year when prescription drug prices, including ivermectin, tend to increase?
A: Prescription drug prices, including ivermectin, tend to increase most frequently in January and July of each year[2].
Q: What factors influence the pricing of ivermectin?
A: The pricing of ivermectin is influenced by regulatory approvals, market competition, demand, and production costs[1][3].
Q: Are significant price increases expected for ivermectin in the near future?
A: Significant price increases are less likely for well-established generic drugs like ivermectin, but moderate price adjustments following general market trends are possible[2].
Sources
- FDA.report: NDC 42799-806 Oral Tablet Ivermectin Drug Codes.
- ASPE: Price Increases for Prescription Drugs, 2016-2022.
- GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030.
- DailyMed: IVERMECTIN tablet.
